- Investing.com
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. OpGen, Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
Metrics to compare | OPGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOPGNPeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −0.7x | −0.7x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 1.1x | 2.6x | |
Price / LTM Sales | 0.0x | 9.4x | 3.4x | |
Upside (Analyst Target) | - | 156.3% | 39.2% | |
Fair Value Upside | Unlock | 19.5% | 6.1% | Unlock |